McMillan GC.Historical review of research on atherosclerosis. Adv Exp Med Biol1995; 369: 1-6.
2.
Bostrom K, Watson KE, Horn S, Lam T, Norton B, Demer LL.Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest1994; 91: 1800-1809.
3.
Watson KE, Bostrom K, Ravindranath Ret al.TGF-beta 1 and 25- hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest1994; 93: 2106-2113.
4.
Parhami F, Morrow AD, Balucan Jet al.Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol1997; 17: 680-687.
5.
Mohler ER, Chawla MK, Chang AWet al.Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis1999; 8: 254-260.
6.
O’Brien ER, Garvin MR, Stewart DKet al.Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb1994; 14: 1648-1656.
7.
Mohler ER, Adam LP, McClelland Pet al.Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol1997; 17: 547-552.
8.
Mohler ER, Gannon FH, Reynolds Cet al.Bone formation and inflammation in cardiac valves. Circulation2001; 103: 1522-1528.
9.
O’Brien KD, Kuusisto J, Reichenbach DDet al.Osteopontin is expressed in human aortic valvular lesions. Circulation1995; 92: 2163-2168.
10.
Otto CM, Kuusisto J, Reichenbach DDet al.Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis: histological and immunohistochemical studies. Circulation1994; 90: 844-853.
11.
Mohler ER III.Are atherosclerotic processes involved in aortic-valve calcification?Lancet2000; 356: 524-525.
12.
Hunt JL, Fairman R, Mitchell MEet al.Bone formation in carotid plaques: a clinicopathological study. Stroke2002; 33: 1214-1219.
13.
Johnson JM, Kennelly MM, Decesare Det al.Natural history of asymptomatic carotid plaque. Arch Surg1985; 120: 1010-1012.
14.
Mathiesen EB, Bonaa KH, Joakimsen O.Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the TROMSO study. Circulation2001; 103: 2171-2175.
Cohen A, Tzourio C, Bertrand Bet al.Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke. Circulation1997; 96: 3838-3841.
17.
Mintz GS, Pichard AD, Popma JJet al.Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angio-graphic and intravascular ultrasound study. J Am Coll Cardiol1997; 29: 268-274.
18.
Beckman JA, Ganz J, Creager MAet al.Relationship of clinical presentation and calcification of culprit coronary artery stenoses. Arterioscler Thromb Vasc Biol2001; 21: 1618-1622.
19.
Callister TQ, Raggi P, Cooli Bet al.Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med1998; 339: 1972-1978.